Hypothesis\n\nLysosomal lipid lock sustains mTORC1‑driven autophagy suppression in aging\n\nMechanistic rationale\n- Mitochondrial dysfunction in aged cells raises ROS and reduces NAD+, leading to AMPK inhibition and persistent mTORC1 activation on the lysosomal surface {3} {2}.\n- Concurrently, impaired lysosomal cholesterol efflux causes accumulation of free cholesterol and oxidized phospholipids within the lysosome lumen and membrane {5}.\n- These lipids disrupt the Ragulator‑Rag GTPase complex, preventing its conformational shift that normally releases mTORC1 during amino‑acid scarcity {6}.\n- As a result, mTORC1 remains tethered to the lysosome irrespective of upstream nutrient signals, keeping ULK1 phosphorylated at Ser757 and blocking autophagy initiation.\n- The block is reinforced by declining cargo receptors (p62, OPTN) and RUBCN up‑regulation, which are downstream consequences of sustained mTORC1 activity {4}.\n\nTestable predictions\n1. In fibroblasts or muscle tissue from old mice, lysosomal cholesterol content will correlate positively with mTORC1 lysosomal localization and inversely with autophagic flux (LC3‑II turnover).\n2. Acute treatment with an LXR agonist (e.g., GW3965) will increase lysosomal cholesterol export, reduce Ragulator‑mTORC1 colocalization, and restore autophagy flux without altering NAD+ levels {7}.\n3. Genetic knock‑down of NPC1 (to raise lysosomal cholesterol) in young cells will mimic the aged phenotype: mTORC1 stays lysosome‑bound, autophagy is suppressed, and ROS rises {8}.\n4. Conversely, overexpressing a cholesterol‑sensing mutant of Ragulator that cannot bind lipids will prevent mTORC1 retention despite high lysosomal cholesterol, rescuing autophagy.\n\nExperimental approach\n- Measure lysosomal cholesterol using filipin staining and quantify mTORC1 localization via immunofluorescence for RagB and mTOR.\n- Assess autophagy flux with LC3‑II and p62 immunoblots in the presence and absence of bafilomycin A1.\n- Manipulate LXR activity with GW3965 or siRNA against LXRα/β and repeat the above readouts.\n- Use CRISPRi to knockdown NPC1 or overexpress Ragulator mutants and evaluate the same parameters.\n\nImplications\nIf validated, this hypothesis shifts the focus from purely metabolic signaling to lysosomal lipid homeostasis as a controllable node that gates mTORC1 activity. It suggests that LXR‑mediated cholesterol efflux could re‑engage autophagy in aged tissues, complementing NAD+‑based strategies and providing a therapeutic avenue that bypasses the need to overcome mTORC1 hyperactivation directly.